PR

Pami Reddy Chennakeshavareddy

Active Director Director DIN 11633123
DIN 11633123 First appointment Mar 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Pami Reddy Chennakeshavareddy

Data last updated:

Pami Reddy Chennakeshavareddy is a Director at Rajoo Pharmaceuticals Private Limited (since 2026).

DIN 11633123
Primary Designation Director
First Appointment 27 Mar 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Mar 20262026Active

Board colleagues of Pami Reddy Chennakeshavareddy

NameDINCompanyDesignation
Naveen Teja Kankanala11633122Rajoo Pharmaceuticals Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Rajoo Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Pami Reddy Chennakeshavareddy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pami Reddy Chennakeshavareddy

Pami Reddy Chennakeshavareddy currently holds 1 directorship: Rajoo Pharmaceuticals Private Limited (Director, since 27 Mar 2026).

Pami Reddy Chennakeshavareddy was first appointed on 27 Mar 2026 as Director at Rajoo Pharmaceuticals Private Limited.

The current boards of Pami Reddy Chennakeshavareddy's companies include Naveen Teja Kankanala (Rajoo Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available